These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 120456)

  • 1. Studies on the detoxification of Pseudomonas aeruginosa exotoxin.
    Abe C; Takeshi K; Homma JY; Kato I
    Jpn J Med Sci Biol; 1979 Apr; 32(2):88-90. PubMed ID: 120456
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the detoxification of Pseudomonas aeruginosa exotoxin.
    Abe C; Takeshi K; Homma JT
    Jpn J Exp Med; 1978 Apr; 48(2):183-6. PubMed ID: 101699
    [No Abstract]   [Full Text] [Related]  

  • 3. Passive hemagglutination reaction using formalinized sheep erythrocytes treated with tannic acid and coated with exotoxin of Pseudomonas aeruginosa.
    Takeshi K; Homma JY
    Jpn J Exp Med; 1978 Dec; 48(6):497-501. PubMed ID: 108439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin necrotizing property of Pseudomonas aeruginosa exotoxin.
    Takeshi K; Homma JY; Kato I; Saito H
    Jpn J Exp Med; 1977 Aug; 47(4):323-5. PubMed ID: 411972
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pseudomonas aeruginosa toxoid].
    Ianishevskaia MN
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):27-32. PubMed ID: 3922181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa exotoxin A.
    Pollack M
    N Engl J Med; 1980 Jun; 302(24):1360-2. PubMed ID: 6769039
    [No Abstract]   [Full Text] [Related]  

  • 7. Pseudomonas aeruginosa. II. Experimental acellular vaccine of an endotoxin and anatoxin type.
    Bĕlohlávek S; Pavlík V; Rencová J; Stránský V; Nováková L; Sourek J; Výmola F
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(3):343-52. PubMed ID: 3119704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of exotoxin A in pseudomonas disease and immunity.
    Pollack M
    Rev Infect Dis; 1983; 5 Suppl 5():S979-84. PubMed ID: 6419320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pseudomonas aeruginosa exotoxin A and its role in the pathogenesis of pyocyaneus infection].
    Vertiev IuV; Brodinova NS; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Feb; (2):13-9. PubMed ID: 6787818
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental preventive properties of a complex of Pseudomonas aeruginosa and Clostridium tetani anatoxins].
    Podgornaia LG; Dziuban NF; Kalinichenko NF; Isaeva SIa
    Mikrobiol Zh (1978); 1987; 49(5):55-8. PubMed ID: 3150503
    [No Abstract]   [Full Text] [Related]  

  • 11. Roles of exoenzymes and exotoxin in the pathogenicity of Pseudomonas aeruginosa and the development of a new vaccine.
    Homma JY
    Jpn J Exp Med; 1980 Jun; 50(3):149-65. PubMed ID: 6776324
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recent progress of Pseudomonas aeruginosa infections; pathological mechanisms of new toxic metabolites].
    Homma JY
    Nihon Rinsho; 1991 Oct; 49(10):2201-6. PubMed ID: 1749074
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunogenic properties of the liposomal form of Pseudomonas aeruginosa anatoxin].
    Minukhin VV; Brodinova NS; Tsyganenko AIa; Ivanova NN; Vasil'chenko VN; Sennikov GA
    Vestn Akad Med Nauk SSSR; 1990; (8):44-7. PubMed ID: 2125778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The protective properties of Pseudomonas aeruginosa anatoxin].
    Dziuban NF; Podgornaia LG
    Mikrobiol Zh (1978); 1985; 47(2):83-6. PubMed ID: 3939835
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man.
    Pollack M; Young LS
    J Clin Invest; 1979 Feb; 63(2):276-86. PubMed ID: 429553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the protective properties of native and sorbed Pseudomonas aeruginosa anatoxins].
    Dziuban NF
    Mikrobiol Zh (1978); 1983; 45(6):85-7. PubMed ID: 6443863
    [No Abstract]   [Full Text] [Related]  

  • 17. Mouse-protection experience with monovalent Pseudomonas aeruginosa vaccine.
    Sourek J; Výmola F; Zelenková L
    Zentralbl Bakteriol A; 1980 Mar; 246(3):353-62. PubMed ID: 6775443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of Pseudomonas aeruginosa exotoxin by affinity chromatography.
    Taylor NS; Pollack M
    Infect Immun; 1978 Jan; 19(1):66-70. PubMed ID: 415008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of Pseudomonas aeruginosa exotoxin on various nonspecific factors of immunologic reactivity in an experiment].
    Dziubak ST
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jun; (6):69-72. PubMed ID: 6412491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics, isolation and role in the infectious process of Pseudomonas aeruginosa protease.
    Brodinova NS; Moroz AF; Luchina TYa
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(1):69-76. PubMed ID: 6406591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.